Samuele Pizzocri

Showing 1-2 of 2 articles

Author Luca Testa

Right subclavian approach as a feasible alternative for transcatheter aortic valve implantation with the CoreValve ReValving System

Testa L, Brambilla N, Laudisa M-L, De Carlo M, Lanotte S, Latini R, Pizzocri S, Casavecchia M, Agnifili M, Giannini C, Bortolotti U, Petronio A, Bedogni F

October 26, 2012 | 10.4244/EIJV8I6A107

Author Luca Testa

Drug eluting stents versus bare metal stents in the treatment of saphenous vein graft disease: a systematic review and meta-analysis

Testa L, Agostoni P, Vermeersch P, Biondi-Zoccai G, van Gaal W, Bhindi R, Brilakis E, Latini R, Laudisa M-L, Pizzocri S, Lanotte S, Brambilla N, Banning A, Bedogni F

September 30, 2010

1

Latest news

Antiplatelet strategies for complex PCI, are all DES equal at 10-year follow-up? cost-effectiveness of TAVR…find all the answers in the new issue

(Intravascular lithotripsy (3.5 mm Shockwave; left), followed by balloon dilatation (4.0 mm NC; right))

December 6, 2019

Discover 5 new trials: GALILEO, CONDI-2/ERIC-PCI, EVOLUTE II-5 years, SCOPE and Excel 5 years

(The Trials book is supported by Biotronik)

December 13, 2019

New this week: A Dose-response Meta Analysis, stroke after MitraClip and more

December 10, 2019

The challenge of innovation for the (interventional?) cardiology world

December 6, 2019

Guidance Papers

Guidelines, consensus & position papers

2019 – A leap year for valvular heart disease

(Course directors PCR London Valves 2019)

November 15, 2019

Last week's JAA's: EXTREME Study, Stent Optimization and more

December 3, 2019

Coronary

Valvular disease

Heart failure

Peripheral

Hypertension

Stroke